About STRATA Skin Sciences (NASDAQ:SSKN)
STRATA Skin Sciences, Inc., a medical technology company, engages in developing and commercializing products for the treatment of dermatological disorders. Its products include XTRAC and VTRAC devices used for the treatment of psoriasis, vitiligo, and other skin disorders; and MelaFind system, an instrument for aiding dermatologists in the evaluation of clinically atypical pigmented skin lesions, when a dermatologist chooses to obtain additional information before making a final decision to biopsy in order to rule out melanoma. The company was formerly known as MELA Sciences, Inc. and changed its name to STRATA Skin Sciences, Inc. in December 2015. STRATA Skin Sciences, Inc. was founded in 1989 and is based in Horsham, Pennsylvania.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:SSKN
CUSIPN/A
Phone215-619-3200
Debt
Debt-to-Equity Ratio0.35%
Current Ratio1.40%
Quick Ratio1.01%
Price-To-Earnings
Trailing P/E Ratio0.64
Forward P/E Ratio-1.21
P/E GrowthN/A
Sales & Book Value
Annual Sales$31.45 million
Price / Sales0.19
Cash Flow$0.5045 per share
Price / Cash2.51
Book Value$5.46 per share
Price / Book0.23
Profitability
EPS (Most Recent Fiscal Year)$1.97
Net Income$-18,830,000.00
Net Margins-58.76%
Return on Equity-39.24%
Return on Assets-16.77%
Miscellaneous
Employees98
Outstanding Shares4,730,000
STRATA Skin Sciences (NASDAQ:SSKN) Frequently Asked Questions
What is STRATA Skin Sciences' stock symbol?
STRATA Skin Sciences trades on the NASDAQ under the ticker symbol "SSKN."
When did STRATA Skin Sciences' stock split? How did STRATA Skin Sciences' stock split work?
Shares of STRATA Skin Sciences reverse split on Thursday, July 10th 2014. The 1-10 reverse split was announced on Thursday, July 3rd 2014. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 9th 2014. An investor that had 100 shares of STRATA Skin Sciences stock prior to the reverse split would have 10 shares after the split.
How were STRATA Skin Sciences' earnings last quarter?
STRATA Skin Sciences Inc (NASDAQ:SSKN) posted its quarterly earnings results on Monday, April, 2nd. The medical device company reported ($0.10) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($1.27) by $1.17. The medical device company had revenue of $8.60 million for the quarter, compared to analyst estimates of $7.35 million. STRATA Skin Sciences had a negative return on equity of 39.24% and a negative net margin of 58.76%. View STRATA Skin Sciences' Earnings History.
When is STRATA Skin Sciences' next earnings date?
What price target have analysts set for SSKN?
2 analysts have issued 12 month price objectives for STRATA Skin Sciences' stock. Their forecasts range from $7.00 to $12.00. On average, they expect STRATA Skin Sciences' stock price to reach $9.50 in the next twelve months. View Analyst Ratings for STRATA Skin Sciences.
Who are some of STRATA Skin Sciences' key competitors?
Some companies that are related to STRATA Skin Sciences include Cytori Therapeutics (CYTX), InVivo Therapeutics (NVIV), Valeritas (VLRX), Alliqua BioMedical (ALQA), Neurometrix (NURO), Atossa Genetics (ATOS), Regenicin (RGIN), United American Healthcare (UAHC), Amedica (AMDA), Avinger (AVGR), Encision (ECIA), Cytocore (MDIT), Calmare Therapeutics (CTTC), TearLab (TEAR) and Viatar CTC Solutions (VRTT).
Who are STRATA Skin Sciences' key executives?
STRATA Skin Sciences' management team includes the folowing people:
- Mr. Frank J. McCaney, Chief Exec. Officer, Pres and Director (Age 63)
- Mr. Michael R. Stewart, Independent Consultant (Age 61)
- Mr. Jay Sturm, Corp. Counsel and Corp. Sec. (Age 62)
- Dr. Darrell S. Rigel M.D., Ms, Faad, Chief Medical Advisor (Age 67)
- Dr. Dina Gutkowicz-Krusin Ph.D., Director of Clinical Studies
Has STRATA Skin Sciences been receiving favorable news coverage?
Headlines about SSKN stock have trended somewhat positive on Thursday, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. STRATA Skin Sciences earned a news sentiment score of 0.04 on Accern's scale. They also assigned media headlines about the medical device company an impact score of 47.23 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near term.
How do I buy shares of STRATA Skin Sciences?
Shares of SSKN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is STRATA Skin Sciences' stock price today?
One share of SSKN stock can currently be purchased for approximately $1.2662.
How big of a company is STRATA Skin Sciences?
STRATA Skin Sciences has a market capitalization of $5.78 million and generates $31.45 million in revenue each year. The medical device company earns $-18,830,000.00 in net income (profit) each year or $1.97 on an earnings per share basis. STRATA Skin Sciences employs 98 workers across the globe.
How can I contact STRATA Skin Sciences?
STRATA Skin Sciences' mailing address is 100 LAKESIDE DRIVE SUITE 100, HORSHAM PA, 19044. The medical device company can be reached via phone at 215-619-3200 or via email at [email protected]
MarketBeat Community Rating for STRATA Skin Sciences (SSKN)
MarketBeat's community ratings are surveys of what our community members think about STRATA Skin Sciences and other stocks. Vote "Outperform" if you believe SSKN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SSKN will underperform the S&P 500 over the long term. You may vote once every thirty days.
STRATA Skin Sciences (NASDAQ:SSKN) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
2 Wall Street analysts have issued ratings and price targets for STRATA Skin Sciences in the last 12 months. Their average twelve-month price target is $9.50, suggesting that the stock has a possible upside of 650.28%. The high price target for SSKN is $12.00 and the low price target for SSKN is $7.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $9.50 | $9.50 | $9.50 | $12.00 |
| Price Target Upside: | 650.28% upside | 685.12% upside | 685.12% upside | 585.71% upside |
STRATA Skin Sciences (NASDAQ:SSKN) Consensus Price Target History
STRATA Skin Sciences (NASDAQ:SSKN) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 11/10/2017 | HC Wainwright | Reiterated Rating | Buy | $7.00 | N/A |  |
| 5/16/2017 | Rodman & Renshaw | Boost Price Target | Buy -> Buy | $1.50 -> $12.00 | High | |
(Data available from 4/26/2016 forward)
STRATA Skin Sciences (NASDAQ:SSKN) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
STRATA Skin Sciences (NASDAQ SSKN) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 12.92%
Institutional Ownership Percentage: 20.45%
STRATA Skin Sciences (NASDAQ SSKN) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 11/28/2016 | Frank J Mccaney | CEO | Buy | 20,000 | $0.51 | $10,200.00 | 8,865 | |
| 3/11/2016 | Healthcare Master Fun Broadfin | Major Shareholder | Sell | 266,000 | $1.31 | $348,460.00 | | |
| 5/22/2014 | Anthony J Dimun | Director | Buy | 87,500 | $0.38 | $33,250.00 | | |
| 2/5/2014 | David Stone | Director | Buy | 13,514 | $0.74 | $10,000.36 | 23,514 | |
| 2/5/2014 | Robert Coradini | Chairman | Buy | 67,567 | $0.74 | $49,999.58 | 139,024 | |
| 2/5/2014 | Rosemary Crane | CEO | Buy | 67,570 | $0.74 | $50,001.80 | 67,570 | |
| 6/28/2013 | Robert Coradini | CEO | Buy | 15,000 | $0.99 | $14,850.00 | | |
| 6/27/2013 | Anne M Egger | Director | Buy | 11,000 | $0.90 | $9,900.00 | | |
| 6/27/2013 | Robert Coradini | CEO | Buy | 15,000 | $0.87 | $13,050.00 | | |
| 6/26/2013 | Luann Via | Director | Buy | 15,000 | $0.79 | $11,850.00 | | |
| 6/25/2013 | Richard I Steinhart | CFO | Buy | 3,000 | $0.81 | $2,430.00 | | |
| 6/24/2013 | Kathryn B Swintek | Director | Buy | 17,000 | $0.73 | $12,410.00 | | |
| 6/24/2013 | Robert Coradini | CEO | Buy | 50,000 | $0.72 | $36,000.00 | | |
| 6/21/2013 | Kathryn B Swintek | Director | Buy | 3,000 | $0.79 | $2,370.00 | | |
| 6/20/2013 | Mindy C Meads | Director | Buy | 5,070 | $0.79 | $4,005.30 | | |
| 6/19/2013 | David K Stone | Director | Buy | 10,000 | $0.82 | $8,200.00 | | |
| 5/3/2013 | Joseph V Gulfo | CEO | Buy | 25,000 | $1.08 | $27,000.00 | | |
| 3/13/2013 | Joseph V Gulfo | CEO | Buy | 20,000 | $1.15 | $23,000.00 | | |
| 11/12/2012 | Joseph V Gulfo | CEO | Buy | 10,000 | $2.68 | $26,800.00 | | |
(Data available from 1/1/2013 forward)
STRATA Skin Sciences (NASDAQ SSKN) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Should You Buy Strata Skin Sciences Inc (NASDAQ:SSKN) Now?
finance.yahoo.com - April 10 at 4:39 PM |
| STRATA Skin Sciences Reports Fourth Quarter and Fiscal Year 2017 Financial Results
finance.yahoo.com - April 10 at 9:40 AM |
| STRATA Skin Sciences Announces $17 Million Equity Financing led by Accelmed Growth Partners; Appointment of Industry Veteran as Interim CEO
finance.yahoo.com - April 10 at 9:40 AM |
 | ValuEngine Lowers STRATA Skin Sciences (SSKN) to Strong Sell
www.americanbankingnews.com - April 8 at 10:47 AM |
| STRATA Skin Sciences (SSKN) Given a $12.00 Price Target by HC Wainwright Analysts
www.americanbankingnews.com - April 6 at 3:32 PM |
| Analysts Set $7.00 Price Target for Strata Skin Sciences, Inc. (SSKN)
www.americanbankingnews.com - April 4 at 11:12 PM |
| Strata Skin Sciences (SSKN) and Its Rivals Head to Head Review
www.americanbankingnews.com - April 4 at 11:20 AM |
 | STRATA Skin Sciences (SSKN) Reports $17M Equity Financing led by Accelmed Growth Partners; Announces Dr. Doley Rafaeli as Interim CEO
www.streetinsider.com - April 3 at 9:33 AM |
 | STRATA Skin Sciences announces $17M equity financing; appoints new interim CEO
seekingalpha.com - April 2 at 9:45 AM |
| Critical Survey: Strata Skin Sciences (SSKN) & Centene (CNC)
www.americanbankingnews.com - March 30 at 1:36 PM |
| STRATA Skin Sciences, Inc. Reschedules Fiscal 2017 Financial Results and Corporate Update Call to Monday, April 2 at 8:30 am Eastern Time
finance.yahoo.com - March 29 at 4:37 PM |
| STRATA Skin Sciences, Inc. to Report Fiscal 2017 Financial Results on Thursday, March 29
finance.yahoo.com - March 27 at 9:40 AM |
| Reviewing Strata Skin Sciences (SSKN) & Its Rivals
www.americanbankingnews.com - March 25 at 3:21 PM |
 | BRIEF-Strata Skin Sciences Delays Q4 Results Partly Due To Extended Power Outage At Horsham
www.reuters.com - March 7 at 5:28 PM |
| STRATA Skin Sciences, Inc. Delays Fourth Quarter and Fiscal 2017 Financial Results
finance.yahoo.com - March 6 at 4:57 PM |
| Strata Skin Sciences (SSKN) Upgraded to Hold at ValuEngine
www.americanbankingnews.com - March 4 at 9:52 AM |
| Strata Skin Sciences (SSKN) to Release Earnings on Wednesday
www.americanbankingnews.com - February 28 at 1:58 AM |
| STRATA Skin Sciences, Inc. to Report 4th Quarter and Fiscal 2017 Financial Results on Thursday, March 8
finance.yahoo.com - February 21 at 9:17 AM |
| Strata Skin Sciences (SSKN) Lifted to Hold at Zacks Investment Research
www.americanbankingnews.com - January 11 at 12:06 PM |
| SABBY MANAGEMENT, LLC Sends Letter to STRATA Skin Sciences (SSKN) Expressing Dissatisfaction with Certain Actions
www.streetinsider.com - January 4 at 3:42 PM |
| ValuEngine Downgrades Strata Skin Sciences (SSKN) to Strong Sell
www.americanbankingnews.com - January 1 at 9:58 AM |
| STRATA Skin Sciences, Inc. :SSKN-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017
finance.yahoo.com - December 25 at 4:24 PM |
| STRATA Skin Sciences Announces Appointment of LuAnn Via as Chairperson of the Board
finance.yahoo.com - December 20 at 11:24 AM |
| BRIEF-Strata Skin Sciences Announces Exploration Of Strategic Alternatives
www.reuters.com - December 18 at 11:52 AM |
| STRATA Skin Sciences (SSKN) to Explore Strategic Alternatives
www.streetinsider.com - December 18 at 11:52 AM |
| STRATA Skin Sciences Announces Exploration of Strategic Alternatives
finance.yahoo.com - December 18 at 11:52 AM |
| STRATA Skin Sciences Announces Departure of Chief Financial Officer
finance.yahoo.com - December 7 at 11:50 AM |
| Zacks Investment Research Lowers Strata Skin Sciences, Inc. (SSKN) to Sell
www.americanbankingnews.com - November 16 at 10:00 AM |
| Edited Transcript of SSKN earnings conference call or presentation 9-Nov-17 9:30pm GMT
finance.yahoo.com - November 14 at 8:15 AM |
| STRATA Skin Sciences' (SSKN) CEO Frank McCaney on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 11 at 2:03 PM |
| Strata Skin Sciences, Inc. (SSKN) Price Target Cut to $7.00
www.americanbankingnews.com - November 10 at 10:24 AM |
| STRATA Skin Sciences Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 9 at 7:00 PM |
| STRATA Skin Sciences, Inc. to Host Earnings Call
finance.yahoo.com - November 9 at 1:59 PM |
| What You Must Know About Strata Skin Sciences Inc’s (SSKN) Financial Strength
finance.yahoo.com - November 4 at 5:29 PM |
| Strata Skin Sciences, Inc. (SSKN) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - November 1 at 4:50 AM |
| STRATA Skin Sciences, Inc. to Report 3rd Quarter 2017 Financial Results on Thursday, November 9
finance.yahoo.com - October 28 at 7:25 AM |
| STRATA Skin Sciences, New Distribution Deal and Debt Restructuring, Analysts View
finance.yahoo.com - October 28 at 7:25 AM |
| This Strata Skin Analyst Is Modeling For More Than 400% Upside In Stock
finance.yahoo.com - October 19 at 9:20 AM |
| Today's Research Reports on Trending Tickers: Myriad Genetics and Strata Skin Sciences
finance.yahoo.com - October 19 at 9:20 AM |
| STRATA Skin Sciences inks deal with aesthetic medical market-focused group purchasing organization; shares ahead 31% after hours
seekingalpha.com - October 18 at 8:54 AM |
| STRATA Skin Sciences Announces Agreement with MedResults Network, a GPO Exclusive to the Aesthetic Medical Market
finance.yahoo.com - October 18 at 8:54 AM |
 | 11 Stocks Moving In Tuesday's After-Hours Session
feeds.benzinga.com - October 17 at 6:16 PM |
| STRATA Skin Sciences, Inc. :SSKN-US: Earnings Analysis: Q2, 2017 By the Numbers : October 5, 2017
finance.yahoo.com - October 6 at 12:59 PM |
| Strata Skin Sciences (SSKN) versus Ekso Bionics Holdings (EKSO) Head to Head Comparison
www.americanbankingnews.com - October 4 at 9:12 AM |
| STRATA Skin Sciences Announces Closing of Agreement to Eliminate $40.7 Million of Outstanding Senior Secured Convertible Debentures
finance.yahoo.com - October 3 at 12:56 PM |
| Ekso Bionics Holdings (EKSO) and Strata Skin Sciences (SSKN) Critical Comparison
www.americanbankingnews.com - September 22 at 2:16 PM |
| Analyzing Strata Skin Sciences (SSKN) and Ekso Bionics Holdings (EKSO)
www.americanbankingnews.com - September 22 at 9:00 AM |
| Ekso Bionics Holdings (EKSO) versus Strata Skin Sciences (SSKN) Critical Review
www.americanbankingnews.com - September 21 at 2:28 PM |
| What Is Strata Skin Sciences Inc’s (SSKN) Share Price Doing?
finance.yahoo.com - September 19 at 8:04 AM |
| Head-To-Head Contrast: Ekso Bionics Holdings (EKSO) vs. Strata Skin Sciences (SSKN)
www.americanbankingnews.com - September 13 at 8:10 PM |
STRATA Skin Sciences (NASDAQ:SSKN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
STRATA Skin Sciences (NASDAQ:SSKN) Income Statement, Balance Sheet and Cash Flow Statement
STRATA Skin Sciences (NASDAQ SSKN) Stock Chart for Thursday, April, 26, 2018
Loading chart…
